Lonza Group (OTCMKTS:LZAGY) Shares Gap Up – Still a Buy?

Lonza Group Ag (OTCMKTS:LZAGY) gapped up prior to trading on Tuesday . The stock had previously closed at $61.20, but opened at $63.64. Lonza Group shares last traded at $63.85, with a volume of 1,000 shares trading hands.

Analysts Set New Price Targets

Separately, Zacks Research raised Lonza Group from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 8th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Lonza Group Stock Up 1.8%

The company has a debt-to-equity ratio of 0.42, a current ratio of 2.24 and a quick ratio of 1.77. The company’s 50-day simple moving average is $62.82 and its 200 day simple moving average is $65.19.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.